1. A randomized phase 2 study of temozolomide and bevacizumab or nab‐paclitaxel, carboplatin, and bevacizumab in patients with unresectable stage IV melanoma1234. Issue 3 (22nd August 2012) Authors: Kottschade, Lisa A.; Suman, Vera J.; Perez, Domingo G.; McWilliams, Robert R.; Kaur, Judith S.; Amatruda, Thomas T.; Geoffroy, Francois J.; Gross, Howard M.; Cohen, Peter A.; Jaslowski, Anthony J.; Kosel, Matthew L.; Markovic, Svetomir N. Journal: Cancer Issue: Volume 119:Issue 3(2013) Page Start: 586 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗